Features and Outcomes of Methamphetamine-associated Pulmonary Arterial Hypertension

T. Zamanian, Roham; Hedlin, Haley; Greuenwald, Paul; M. Wilson, David; I. Segal, Joshua; A. Jorden, Michelle; Kudelko, Kristina; Liu, Juliana; Hsi, Andrew; Rupp, Allyson; J. Sweatt, Andrew; M. Tuder, Rubin; J. Berry, Gerald; Rabinovitch, Marlene; L. Doyle, Ramona; de Jesús Pérez, Vinicio; M. Kawut, Steven

doi:10.1164/rccm.201705-0943oc

Public

Features and Outcomes of Methamphetamine-associated Pulmonary Arterial Hypertension

Published in American Journal of Respiratory and Critical Care Medicine • Sep 21, 2017

Authors:

Roham T. Zamanian

Haley Hedlin

Paul Greuenwald

Abstract

Abstract Rationale Although amphetamines are recognized as “likely” agents to cause drug- and toxin-associated pulmonary arterial hypertension (PAH), (meth)amphetamine-associated PAH (Meth-APAH) has not been well described. Objectives To prospectively characterize the clinical presentation, histopat...

Subject

Medicine

Hazard ratio

Meth-

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!